<DOC>
	<DOC>NCT00037661</DOC>
	<brief_summary>Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.</brief_summary>
	<brief_title>Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>have NonSjogren's associated dry eye disease with symptoms lasting greater than 6 months had intermittent or regular artificial tear use within past 3 months had LASIK surgery had punctal occlusion or cauterization within last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>dry eye</keyword>
</DOC>